• 1
    Brown MT, Cooper JA 1996 Regulation, substrates and functions of src Biochim Biophys Acta 1287:121149.
  • 2
    Soriano P, Montgomery C, Geske R, Bradley A 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice Cell 64:693702.
  • 3
    Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR 1992 Requirement of pp. 60c–src expression for osteoclasts to form ruffled borders and resorb bone in mice J Clin Invest 90:16221627.
  • 4
    Lowe C, Yoneda T, Boyce BF, Chen H, Mundy GR, Soriano P 1993 Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts Proc Natl Acad Sci USA 90:44854489.
  • 5
    Roodman GD 1996 Advances in bone biology: The osteoclast Endocr Rev 17:308332.
  • 6
    Gattei V, Bernabei PA, Pinto A, Bezzini R, Ringressi A, Formigli L, Tanini A, Attadia V, Brandi ML 1992 Phorbol ester induced osteoclast-like differentiation of a novel human leukemic cell line (FLG 29.1) J Cell Biol 116:437447.
  • 7
    Masi L, Brandi ML, Gehron Robey P, Crescioli C, Calvo JC, Bernabei P, Kerr JM, Yanagishita M 1995 Biosynthesis of bone sialoprotein by a human osteoclast-like cell line (FLG 29.1) J Bone Miner Res 10:187196.
  • 8
    Fiorelli G, Gori F, Petilli M, Tanini A, Benvenuti S, Serio M, Bernabei P, Brandi ML 1995 Functional estrogen receptors in a human preosteoclastic cell line Proc Natl Acad Sci USA 92:26722676.
  • 9
    Khalkhali-Ellis Z, Collin-Osdoby P, Li L, Brandi ML, Osdoby P 1997 A human homolog of the 150 kD avian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29.1 cells Calcif Tissue Int 60:187193.
  • 10
    Katagiri K, Katagiri T, Koyama Y, Morikawa M, Yamamoto T, Yoshida T 1991 Expression of src family genes during monocytic differentiation of HL-60 cells J Immunol 146:701707.
  • 11
    Andoniou CE, Thien CBF, Langdon WY 1994 Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene EMBO J 13:45154523.
  • 12
    Tanaka S, Neff L, Baron R, Levy JB 1995 Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways J Biol Chem 270:1434714351.
  • 13
    Tezuka T, Umemori H, Fusaki N, Yagi T, Takata M, Kurosaki T, Yamamoto T 1996 Physical and functional association of the cbl protooncogene with an src-family protein tyrosine kinase, p53/56lyn, in the B cell antigen receptor-mediated signaling J Exp Med 183:675680.
  • 14
    Panchamoorthy G, Fukazawa T, Miyake S, Soltoff S, Reedquist K, Druker B, Shoelson S, Cantley L, Band H 1996 p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase J Biol Chem 271:31873194.
  • 15
    Tanaka S, Amling M, Neff L, Peyman A, Uhlmann E, Levy JB, Baron R 1996 c-Cbl is downstream of c-Src in a signaling pathway necessary for bone resorption Nature 383:528531.
  • 16
    Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z 1994 Identification of a new catenin: The tyrosine kinase substrate p120cas associates with E-cadherin complexes Mol Cell Biol 14:83338342.
  • 17
    Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H 1994 A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner EMBO J 13:37483756.
  • 18
    Hamasaki K, Mimura T, Morino N, Furuya H, Nakamoto T, Aizawa S, Morimoto C, Yazaki Y, Hirai H, Nojima Y 1996 Src kinase plays an essential role in integrin-mediated tyrosine phosphorylation of Crk-associates substrate p130Cas Biochem Biophys Res Commun 222:338343.
  • 19
    Craig SW, Johnson RP 1996 Assembly of focal adhesions: Progress, paradigms, and portents Curr Opin Cell Biol 8:7485.
  • 20
    Parsons JT 1996 Integrin-mediated signalling: regulation by protein tyrosine kinases and small GTP-binding proteins Curr Opin Cell Biol 8:146152.
  • 21
    Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J 1995 Protein tyrosine kinase Pyk2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions Nature 376:737745.
  • 22
    Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J 1996 A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation Nature 383:547550.
  • 23
    Proud C 1996 p70, S6 kinase: An enigma with variations Trends Biochem Sci 21:181185.
  • 24
    Buscà R, Bertolotto C, Ortonne J-P, Ballotti R 1996 Inhibition of the phosphatidylinositol 3-kinase/p70S6-kinase pathway induces B16 melanoma cell differentiation J Biol Chem 271:3182431830.
  • 25
    Toker A, Cantley LC 1997 Signalling through the lipid products of phosphoinositide-3-OH kinase Nature 387:673676.
  • 26
    Nakamura I, Takahashi N, Sasaki T, Tanaka S, Udagawa N, Murakami H, Kimura K, Kabuyama Y, Kurokawa K, Suda T, Fukui Y 1995 Wortmannin, a specific inhibitor of phosphytidylinositol-3 kinase, blocks osteoclastic bone resorption FEBS Lett 361:7984.
  • 27
    Hall TJ, Schaeublin M, Missbach M 1994 Evidence that c-src is involved in the process of osteoclastic bone resorption Biochem Biophys Res Commun 199:12371244.
  • 28
    Sato M, Bryant HU, Dodge JA, Davis H, Matter WF, Vlahos CJ 1996 Effect of wortmannin analogs on bone in vitro and in vivo J Pharmacol Exp Ther 277:543550.
  • 29
    Ai Z, Misra S, Susa M, Varticovski L, Cohen CM 1995 Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation Exp Cell Res 219:454460.
  • 30
    Yoneda T, Lowe C, Lee C-H, Gutierrez G, Niewolna M, Williams PJ, Izbicka E, Uehara Y, Mundy GR 1993 Herbimycin A, a pp. 60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo J Clin Invest 91:27912795.
  • 31
    Suda T, Udagawa N, Nakamura I, Miyaura C, Takahashi N 1995 Modulation of osteoclast differentiation by local factors Bone 17:87S91S.
  • 32
    Wesolowski G, Duong LT, Lakkakorpi PT, Nagy RM, Tezuka K-I, Tanaka H, Rodan GA, Rodan SB 1995 Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells Exp Cell Res 219:679686.
  • 33
    Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, Takahashi N, Suda T 1996 Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact Endocrinology 137:21872190.
  • 34
    Horne WC, Neff L, Chatterjee D, Lomri A, Levy JB, Baron R 1992 Osteoclasts express high levels of pp. 60c–src in association with intracellular membranes J Cell Biol 119:10031013.
  • 35
    Lowell CA, Niwa M, Soriano P, Varmus HE 1996 Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis Blood 87:17801792.
  • 36
    Salgia R, Avraham S, Pisick E, Li J-L, Raja S, Greenfield EA, Sattler M, Avraham H, Griffin JD 1996 The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells J Biol Chem 271:3122231226.
  • 37
    Li J, Avraham H, Rogers RA, Raja S, Avraham S 1996 Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes Blood 88:417428.
  • 38
    Astier A, Avraham H, Manie SN, Groopman J, Canty T, Avraham S, Freedman AS 1997 The related adhesion focal tyrosine kinase is tyrosine-phosphorylated after beta1-integrin stimulation in B cells and binds to p130cas J Biol Chem 272:228232.
  • 39
    Feuerbach D, Feyen JH 1997 Expression of the cell-adhesion molecule VCAM-1 by stromal cells is necessary for osteoclastogenesis FEBS Lett 402:2124.